Rench Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Rench Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,055	Closed	-$219K	–	47
2016 Q3	$219K	Buy	4,055 +20	+0.5%	+$1.28K	0.18%	46
2016 Q2	$297K	Buy	4,035 +428	+12%	+$30.2K	0.24%	37
2016 Q1	$230K	Buy	+3,607	New	+$227K	0.19%	41
2015 Q3	–	Sell	-6,198	Closed	-$412K	–	44
2015 Q2	$412K	Buy	6,198 +780	+14%	+$51.4K	0.36%	35
2015 Q1	$349K	Buy	+5,418	New	+$339K	0.3%	35
2014 Q4	–	Sell	-7,941	Closed	-$406K	–	51
2014 Q3	$406K	Buy	7,941 +166	+2%	+$8.29K	0.35%	33
2014 Q2	$377K	Sell	7,775 -230	-3%	-$11.3K	0.33%	35
2014 Q1	$416K	Sell	8,005 -42,965	-84%	-$2.29M	0.39%	32
2013 Q4	$2.71M	Buy	+50,970	New	+$2.6M	2.62%	20

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Rench Wealth Management's BMY Position: Q4 2016 in Review

Rench Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 4,055 shares — an estimated $219K sold.

Rench Wealth Management first reported a position in BMY in Q4 2013 and held it in 9 quarters. The position peaked at $2.71M in Q4 2013. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Rench Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Rench Wealth Management sold 4,055 Bristol-Myers Squibb shares in Q4 2016, an estimated $219K.
Rench Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 9 quarters.
Rench Wealth Management's Bristol-Myers Squibb position peaked at $2.71M in Q4 2013.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Rench Wealth Management's 13F filing for Q4 2016, filed 14 Feb 2017.